NCT05487456View on ClinicalTrials.gov

Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

November 7, 2022

Conditions
NicotineVapingNicotine Vaping
Interventions
OTHER

P4M3 CA35

Ad libitum use of P4M3 with CA35 cartridges

OTHER

P4M3 CM35

Ad libitum use of P4M3 with CM35 cartridges

OTHER

CIG

Ad libitum use of subject's own preferred brand of cigarettes

OTHER

Smoking Abstinence

Abstention from cigarette smoking

Trial Locations (1)

Unknown

Celerion, Belfast

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY